TURNER DANIEL K III 4
4 · Orexigen Therapeutics, Inc. · Filed Jun 6, 2011
Insider Transaction Report
Form 4
TURNER DANIEL K III
Director
Transactions
- Award
Stock Option (right to buy)
2011-06-02+20,000→ 20,000 totalExercise: $3.18Exp: 2021-06-01→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]1/12th of the original number of shares subject to the option vest on the first day of each calendar month following June 2, 2011. The shares shall become fully vested upon a change of control. These options have a post-termination exercise period of three years.
- [F2]Not applicable.